{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:10:53Z","timestamp":1790644253860,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical University of Bialystok","award":["3-08525F"],"award-info":[{"award-number":["3-08525F"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bcmd.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T13:47:31Z","timestamp":1462024051000},"page":"92-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Flow-cytometry-based evaluation of peripheral blood lymphocytes in prognostication of newly diagnosed DLBCL patients"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-2664","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Rusak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Bo\u0142kun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chociej-Stypu\u0142kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pawlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"K\u0142oczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"D\u0105browska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2016.04.004_bb0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcmd.2015.12.004","article-title":"Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites","volume":"57","author":"Wang","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hon.2132","article-title":"BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma","volume":"33","author":"Burkhard","year":"2015","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0015","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/leu.2011.378","article-title":"BCL2 mutations in diffuse large B-cell lymphoma","volume":"26","author":"Schuetz","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0020","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0025","first-page":"113","article-title":"Utility of flow cytometry in diagnostics and monitoring of lymphomas","volume":"24","author":"\u017beromski","year":"2008","journal-title":"Post. Biol. Kom."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0030","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.171.9.4604","article-title":"CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner","volume":"171","author":"Janssens","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0035","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill B lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-387827-4.00004-8","article-title":"Biological functions of regulatory T cells","volume":"112","author":"Shevach","year":"2011","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0050","first-page":"1","article-title":"Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma","volume":"31","author":"Wei","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0055","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0060","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0065","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0070","first-page":"1","article-title":"XN-series","volume":"1","author":"Matsushita","year":"2011"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12935-014-0085-9","article-title":"Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapy","volume":"14","author":"Yin","year":"2014","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2567.2011.03539.x","article-title":"T regulatory cells in B-cell malignancy - tumour support or kiss of death?","volume":"135","author":"Lindqvist","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm.3442","article-title":"Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas","volume":"20","author":"Afshar-Sterle","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","article-title":"The many roles of FAS receptor signaling in the immune system","volume":"30","author":"Strasser","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0100","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2741\/s114","article-title":"CD4 (+)CD25 (+)Foxp3 (+) regulatory T cells and hematologic malignancies","volume":"2","author":"Kelley","year":"2010","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0105","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.182.3.1469","article-title":"Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis","volume":"182","author":"Strauss","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2008.01.004","article-title":"Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression","volume":"250","author":"Mahnke","year":"2007","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.immuni.2006.07.011","article-title":"Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms","volume":"25","author":"Li","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20062129","article-title":"Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression","volume":"204","author":"Bopp","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0130","doi-asserted-by":"crossref","first-page":"27571","DOI":"10.1074\/jbc.M110.127100","article-title":"Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells","volume":"285","author":"Mandapathil","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4049\/jimmunol.1200507","article-title":"Cutting edge: IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo","volume":"189","author":"Zou","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0140","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3(+) regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2009.2","article-title":"Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host","volume":"6","author":"Qin","year":"2009","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0155","first-page":"3986","article-title":"Roles of CD4+CD25(high) FOXP3+ Tregs in lymphomas and tumors are complex","volume":"13","author":"Ke","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2008.09.013","article-title":"Appraisal of immune response in lymphoproliferative syndromes: a systematic review","volume":"70","author":"Alvaro","year":"2009","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bcmd.2016.04.004_bb0165","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/leu.2015.99","article-title":"Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1","volume":"17","author":"Li","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2016.04.004_bb0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190701824536","article-title":"Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis","volume":"49","author":"Lee","year":"2008","journal-title":"Leuk. Lymphoma"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:32:07Z","timestamp":1761049927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616300390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"alternative-id":["S1079979616300390"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.04.004","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flow-cytometry-based evaluation of peripheral blood lymphocytes in prognostication of newly diagnosed DLBCL patients","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}